guest@0xbase ~$ read-only mode. Posting requires EU location.

Glucagon-like peptide 1 receptor agonists and cancer risk – systematic review (pmc.ncbi.nlm.nih.gov)

· 15d ago · Report · Spotlight this ·

0xBASE INTEL BRIEF

Systematic review of GLP-1RAs and cancer risk
Analysis of preclinical, clinical, and epidemiological studies
Assessment of risk for various cancer types

"A systematic review of GLP-1 receptor agonists (GLP-1RAs) and cancer risk summarizes evidence from multiple studies. It provides foundational data for clinicians and researchers evaluating these drugs in oncology and metabolic health."

#GLP-1 receptor agonists #cancer risk #systematic review

Read article on pmc.ncbi.nlm.nih.gov → | More from pmc.ncbi.nlm.nih.gov

Discussion Matrix

0 segments

no comments yet.